Eleven isoquinoline alkaloids (1-11) were isolated from dried leaves of Peumus boldus Mol. by standard chromatographic methods. The chemical structures were elucidated by MS, and 1D and 2D NMR spectroscopic analysis, and by comparison with literature data. Compounds isolated in sufficient amount were evaluated for their acetylcholinesterase, and butyrylcholinesterase inhibition activity using Ellman´s method. In the prolyl oligopeptidase assay, Z-Gly-Pro-pnitroanilide was used as substrate. Promising butyrylcholinesterase inhibition activities were demonstrated by two benzylisoquinoline alkaloids, reticuline (8) and N-methylcoclaurine (9), with IC 50 values of 33.6 ± 3.0 μM and 15.0 ± 1.4 μM, respectively. Important prolyl oligopeptidase inhibition activities were shown by N-methyllaurotetanine (6) and sinoacutine (4) with IC 50 values of 135.4 ± 23.2 μM and 143.1 ± 25.4 μM, respectively. Other tested compounds were considered inactive.
Alzheimer's disease (AD) has become one of the most prevalent causes of dementia. It is a progressive neurodegenerative disease with not fully elucidated ethiopathogenesis, although many hypotheses have been discussed. A cholinergic hypothesis is the oldest accepted theory, resulting from the cholinergic deficit emerging in the brains of AD patients. Decrease of acetylcholine (ACh) and other neurotransmitters was demonstrated, and, therefore, inhibition of the enzymes is an effective symptomatic treatment. Acetylcholinesterase (AChE) cleaves ACh to the basic components and maintains a metabolic balance. Cleavage of ACh in the CNS is normally an important factor for the regeneration of neurons. AChE inhibition has become a standard approach for AD treatment [1] . Butyrylcholinesterase (BuChE), which appears to substitute and supplement AChE function in the brain of AD patients, attracted attention as a valuable target to ameliorate the cholinergic deficit [2] .
Prolyl oligopeptidase (POP) is a cytosolic serine peptidase that hydrolyzes small proline-containing peptides such as vasopressin, substance P, and thyrotropin-releasing hormones that are involved in the learning and memory processes [3a,b] . In AD, POP was found co-localizing with β-amyloid, intracellularly, but apparently also extracellularly in β-amyloid plaques and τ protein. POP was also found in astroglial cells. Because of the debris-clearing role of astroglia, they are able to accumulate large amounts of β-amyloid. After overburden, they undergo lysis and form small astrocytic amyloid plaques [3c].
Medicinal plants are attractive sources for anti-dementia drug research. Plenty of studies have proven the effectiveness of inhibitors from plant secondary metabolites with emphasis on cholinesterase, POP, and secretase enzyme families. These targets are current treatments for AD [2, 4] .
Peumus boldus
Mol. (Monimiaceae), known as boldo, is a dioecious tree or shrub, traditionally used in folk medicine, mainly for the treatment of liver ailments [5a] . It is endemic to Chile and extends from 30° (Limari Province) to 41° (Osorno Province), where it is found scattered on sunny dry slopes [5b]. Boldo leaves contain tannins, essential oils (mainly ascaridol and cineol) and flavonoids [5a, c, d] . The most important secondary metabolites isolated from boldo leaves and bark are isoquinoline alkaloids, which can be divided into several structural types. The most abundant are aporphine-type, of which boldine is the main example [5a] . In the course of screening for natural cholinesterase inhibitors, we found that the alkaloid extract of leaves of Peumus boldus showed promising AChE and BuChE inhibition activity with IC 50 values of 69.7 ± 11.2 µg/mL and 46.9 ± 7.1 µg/mL, respectively. In the present study we report the isolation of isoquinoline alkaloids from the leaves of P. boldus and the inhibitory effect of these compounds on the activity of erythrocyte AChE, plasma BuChE and POP.
Extensive chromatographic purification led to the isolation of eleven known isoquinoline alkaloids (Figure 1 structural types. Their structures were determined by comparison of their MS and NMR spectra with literature data, and additional physical properties as: (7) [7c], (+)-reticuline (8) [6c], (+)-N-methylcoclaurine (9) [7f, g], (-)-pallidine (10) [7h] and (+)-laurotetanine (11) [7i]. Compounds 1-4, 6-8, and 11 have been previously isolated from P. boldus. Glaziovine (5), N-methylcoclaurine (9) and pallidine (10) are reported for the first time for P. boldus. Glaziovine (5) belongs to the small proaporphine group of isoquinoline alkaloids and was originally isolated from Ocotea glaziovii (Lauraceae) [7j], and as a major component from the leaves of Duguetia vallicola (Annonaceae) [7d]. Pallidine (10) has already been isolated from Corydalis pallida (Fumariaceae) [7k] . N-Methylcoclaurine (9) together with reticuline (8) are intermediates in the biosynthesis of isoquinoline alkaloids; in minor amounts they can be found in a wide range of alkaloidal plants [7l].
All isolated compounds were assayed for their HuAChE, HuBuChE and POP inhibition activities. Galanthamine hydrobromide and huperzine A were used as positive controls in the HuAChE and HuBuChE assays, and Z-Pro-prolinal and berberine in the POP assay. The results are expressed as IC 50 values (Table 1) .
Various plant species containing isoquinoline alkaloids have a reputation for helping age-related cognitive and memory decline. In some cases AChE inhibition activity has been detected. Unfortunately, in our HuAChE inhibition assay only the aporphine alkaloid boldine (7) and benzylisoquinoline alkaloid N-methylcoclaurine (9) showed moderate activity, with IC 50 values of 192.3 ± 25.9 µM and 220.2 ± 22.3 µM, respectively. Contrary to our results, boldine and laurotetanine are reported as strong inhibitors of AChE with IC 50 values of 8.57 ± 1.4 µM and 3.2 ± 0.3 µM [8] , respectively. In the discussed study, the source of AChE for biological assay is not defined; based on the experimental section, we suppose that commercial AChE from electric eel was used. For the explanation of these contradictions, further biological studies are needed. . The last alkaloid belongs to the benzylisoquinoline type, the same as the most active compounds in the current study reticuline (IC 50 = 33.6 ± 3.0 µM) and N-methylcoclaurine (IC 50 = 15.0 ± 1.4 µM) ( Figure 2 ). N-Methylcoclaurine (9) is the most active compound of all the isoquinoline alkaloids tested so far.
Prolyl oligopeptidase is a cytosolic serine peptidase and recent studies indicate that POP activity is involved in key physiological functions, such as learning and memory, cell division and differentiation, and signaling transduction, as well as in some psychiatric disorders [3b] . Lately POP has gained importance as a target for the treatment of schizophrenia, bipolar affective disorder and cognitive disturbances, such as those present in AD [3a, b] . N-Methyllaurotetanine (6) and sinoacutine (4) showed POP inhibition activity similar to that of the used standard, berberine, but much weaker than that of Z-prolyl-prolinal. Compounds 3, 5, and 9 were not tested for their POP inhibition activity due to the isolation of insufficient amount.
In conclusion, the findings of this study indicate the potential of isoquinoline alkaloids. Thus these compounds are of interest since they can be used as lead compounds in the development of new potent therapeutic drugs to treat neuropsychiatric disorders. AChE inhibition is the most used therapeutic treatment for the symptoms
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of AD, and inhibition of AChE and BuChE continues to be attractive for rational drug design and discovery of mechanismbased inhibitors for the treatment of AD [1] . POP has been suggested to play an important role in the biological regulation of peptide hormones and is recognized to be involved in learning and memory. In recent studies some POP inhibitors have been found to be efficacious anti-dementia drugs [2] . POP inhibition can represent an important supporting approach in AD treatment and therefore the search for new compounds influencing more therapeutic targets connected with AD is required. 
Experimental

Extraction and isolation of alkaloids:
Dried leaves (20 kg) were crushed and exhaustively extracted with ethanol (EtOH) (96%, v/v, 2x) by boiling for 30 min under reflux; the combined extract was filtered and evaporated to dryness under reduced pressure. The crude extract (1.5 kg) was acidified to pH  1.5 with 2% hydrochloric acid (HCl; 5 L), filtered, the filtrate alkalized to pH 9-10 with 10% Na 2 CO 3 and exhaustively extracted with CHCl 3 (3× 9 L). The organic layer was evaporated to give 108.7 g of fluid brown residue. For purification, the residue was dissolved in 1% HCl (700 mL), defatted with diethyl ether (Et 2 O; 3x 250 mL), treated with 10% Na 2 CO 3 (pH 9-10) and extracted with CHCl 3 (3x 250 mL mM, 1 mM, 0,4 mM and 0 mM) were added to the semi-micro cuvette. The reaction was initiated by addition of 33.3 μL 10 mM substrate (ATChI or BuTChI). The final proportion of DTNB and substrate was 1:1. The increase of absorbance (ΔA) at 436 nm for AChE and 412 nm for BuChE was measured for 1 min at 37°C using a spectrophotometer (SynergyTM HT Multi-Detection Microplate Reader). Each measurement was repeated 6 times for every concentration of enzyme preparation. The % inhibition was calculated according to the formula: % 100 100 ∆ ∆ , where ΔA Bl is the increase of absorbance of the blank sample and ΔA Sa is the increase of absorbance of the measured sample. Inhibition potency of the tested compounds was expressed as IC 50 value (concentration of inhibitor, which causes 50% cholinesterase inhibition).
Prolyl oligopeptidase assay:
The same procedure was used as in our previous report [10c].
Statistical analysis:
Calculations were performed using Microsoft Excel software (Redmont, WA, USA) and GraphPad Prism version 5.02 for Windows, GraphPad Software, San Diego, CA, USA.
